Jupiter Life Line Hospitals Limited has informed the Exchange about Transcript
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jupiter Life Line Hospitals reported Q1 FY26 total income of INR 347.6 crore, up 20.5% year-on-year, with EBITDA at INR 78.1 crore (margin 22.5%) and PAT margin at 12.6%. Patient volumes grew 11.7% YoY and ARPOB stood at INR 67,300, though occupancy dipped to 60.1% due to bed additions last year. Management guided that EBITDA margins will be preserved for FY26, but PAT margins will be lower as depreciation rose over INR 10 crore YoY and finance costs climbed on new debt. The company remains net cash positive at ~INR 275 crore (cash INR 600 crore, debt INR 325 crore). Three greenfield hospitals (Dombivli, Mira Road, Pune-Bibvewadi) are progressing, with Dombivli set to launch next year at a capex of ~INR 400 crore for Phase 1, expected to post negative EBITDA in year one and breakeven by year two.
Near-term PAT margins will face pressure from higher depreciation and finance costs, which may weigh on earnings even as operating performance stays steady. Net cash balance and steady volume growth are positives, but investors should brace for a margin dip in FY26 as new hospital losses and capex begin hitting the books.